Genpact enters its third-quarter report with an unusual setup: management is shrinking part of its business on purpose while asking investors to judge it on what replaces that work. Last quarter, the company said it would walk away from roughly two points of commoditized content management and contact center revenue this year, with a somewhat larger dollar hit in 2027. The September quarter is the first full period where that self-disruption shows up in the numbers. The question is whether the faster-growing AI-driven business can absorb the drag cleanly enough to keep the overall story intact.
On the surface, the bar looks manageable. Consensus calls for revenue of about $1.38 billion, up 6.9% from $1.29 billion a year ago. That is solid but unspectacular growth, consistent with the company's at least 7% full-year target. Management guided to $1.369 billion to $1.382 billion, so the Street is sitting near the top of that range and leaves little room for slippage. On earnings, the published consensus of $0.93 appears to be on a different basis than management's adjusted outlook of $1.04 to $1.05 per share. Analysts tracking the adjusted figure sit at about $1.04, the low end of guidance. Genpact also lifted its full-year adjusted EPS outlook to at least $4.09 from more than $4.02, ahead of the roughly $4.05 the Street had modeled. That implies analysts may still be catching up, and the company has room to clear the earnings bar even if revenue only lands in line.
The heart of the report is Advanced Technology Solutions, the agentic and data-driven segment that has become the growth engine. Management raised its full-year ATS growth target three calls in a row, from high-teens to at least 20% and then to at least 25%. Actual growth has run at 24% for two straight quarters, so hitting the new bar requires acceleration in the back half, not just steady performance. A quarter in the mid-to-high 20s would validate the raised target. Another 24% print would quietly raise doubts about whether the guidance stretched too far. Agentic bookings matter just as much. The company says it is tracking toward more than $1 billion in agentic contract value this year, about five times 2025, with more than half coming from new clients. Continued large-deal momentum, after 12 in the first half, would support the case that this is market expansion rather than relabeled legacy work.
The weak spot is core business services, which management guided flat to slightly down for the quarter after about three points of transition impact. Growth there has already faded from 3.7% last year to under 2% in the first half. A worse-than-guided decline, or vague answers on how large the 2027 exit will be, would challenge the idea that the drag is controlled and temporary. Margins are the counterweight. Gross margin has expanded for 13 straight quarters, reaching 36.5%, and another increase would show that walking away from low-value work is paying off in profitability. Cash flow also needs to recover after a soft $72 million second quarter that management blamed on collection timing.
The market has already bought in. Shares are up 11.7% since the last report while the S&P 500 slipped slightly, and sentiment has flipped from moderately bearish to moderately bullish. At $39.20, the stock trades comfortably above its 200-day average of $35.71 but remains about 6% below its post-earnings high of $41.91, so it is not yet pressing a breakout.
That rally raises the stakes. Genpact needs to show that ATS growth is actually accelerating toward 25% and that the core business is shrinking no faster than promised. If both hold, the self-disruption narrative becomes a margin-and-mix upgrade story. If ATS stalls while the exits bite, the recent optimism could prove premature.